110 related articles for article (PubMed ID: 29305109)
1. Scriptaid inhibits cell survival, cell cycle, and promotes apoptosis in multiple myeloma via epigenetic regulation of p21.
Yao R; Han D; Sun X; Xie Y; Wu Q; Fu C; Yao Y; Li H; Li Z; Xu K
Exp Hematol; 2018 Apr; 60():63-72. PubMed ID: 29305109
[TBL] [Abstract][Full Text] [Related]
2. [Effects of HDAC Inhibitor Scriptaid on IM9 Cell Line and Its Mechanism].
Liu LL; Sun XY; Xie Y; Han DY; Yao RS; Xu KL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Aug; 26(4):1116-1121. PubMed ID: 30111417
[TBL] [Abstract][Full Text] [Related]
3. Histone deacetylase inhibitor scriptaid induces cell cycle arrest and epigenetic change in colon cancer cells.
Lee EJ; Lee BB; Kim SJ; Park YD; Park J; Kim DH
Int J Oncol; 2008 Oct; 33(4):767-76. PubMed ID: 18813790
[TBL] [Abstract][Full Text] [Related]
4. Anticancer effect of histone deacetylase inhibitor scriptaid as a single agent for hepatocellular carcinoma.
Liu L; Sun X; Xie Y; Zhuang Y; Yao R; Xu K
Biosci Rep; 2018 Aug; 38(4):. PubMed ID: 29945926
[TBL] [Abstract][Full Text] [Related]
5. A novel histone deacetylase inhibitor, Scriptaid, induces growth inhibition, cell cycle arrest and apoptosis in human endometrial cancer and ovarian cancer cells.
Takai N; Ueda T; Nishida M; Nasu K; Narahara H
Int J Mol Med; 2006 Feb; 17(2):323-9. PubMed ID: 16391833
[TBL] [Abstract][Full Text] [Related]
6. Decitabine, a DNA methyltransferases inhibitor, induces cell cycle arrest at G2/M phase through p53-independent pathway in human cancer cells.
Shin DY; Sung Kang H; Kim GY; Kim WJ; Yoo YH; Choi YH
Biomed Pharmacother; 2013 May; 67(4):305-11. PubMed ID: 23582784
[TBL] [Abstract][Full Text] [Related]
7. Anti-Proliferative Activity of HPOB against Multiple Myeloma Cells via p21 Transcriptional Activation.
Liu L; Sun X; Xie Y; Zhuang Y; Yao R; Xu K
Molecules; 2018 Apr; 23(5):. PubMed ID: 29710846
[TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of germacrone on human hepatoma cell lines through inducing G2/M cell cycle arrest and promoting apoptosis.
Liu Y; Wang W; Fang B; Ma F; Zheng Q; Deng P; Zhao S; Chen M; Yang G; He G
Eur J Pharmacol; 2013 Jan; 698(1-3):95-102. PubMed ID: 23117090
[TBL] [Abstract][Full Text] [Related]
9. Pomalidomide and lenalidomide induce p21 WAF-1 expression in both lymphoma and multiple myeloma through a LSD1-mediated epigenetic mechanism.
Escoubet-Lozach L; Lin IL; Jensen-Pergakes K; Brady HA; Gandhi AK; Schafer PH; Muller GW; Worland PJ; Chan KW; Verhelle D
Cancer Res; 2009 Sep; 69(18):7347-56. PubMed ID: 19738071
[TBL] [Abstract][Full Text] [Related]
10. Synergistic antitumor effects of histone deacetylase inhibitor scriptaid and bortezomib against ovarian cancer cells.
Janyst K; Janyst M; Siernicka M; Lasek W
Oncol Rep; 2018 Apr; 39(4):1999-2005. PubMed ID: 29436692
[TBL] [Abstract][Full Text] [Related]
11. HDAC inhibitor, scriptaid, induces glioma cell apoptosis through JNK activation and inhibits telomerase activity.
Sharma V; Koul N; Joseph C; Dixit D; Ghosh S; Sen E
J Cell Mol Med; 2010 Aug; 14(8):2151-61. PubMed ID: 19583803
[TBL] [Abstract][Full Text] [Related]
12. A novel histone deacetylase inhibitor, scriptaid, enhances expression of functional estrogen receptor alpha (ER) in ER negative human breast cancer cells in combination with 5-aza 2'-deoxycytidine.
Keen JC; Yan L; Mack KM; Pettit C; Smith D; Sharma D; Davidson NE
Breast Cancer Res Treat; 2003 Oct; 81(3):177-86. PubMed ID: 14620913
[TBL] [Abstract][Full Text] [Related]
13. Scriptaid cause histone deacetylase inhibition and cell cycle arrest in HeLa cancer cells: A study on structural and functional aspects.
Janaki Ramaiah M; Naushad SM; Lavanya A; Srinivas C; Anjana Devi T; Sampathkumar S; Dharan DB; Bhadra MP
Gene; 2017 Sep; 627():379-386. PubMed ID: 28668345
[TBL] [Abstract][Full Text] [Related]
14. Azidothymidine hinders arsenic trioxide-induced apoptosis in acute promyelocytic leukemia cells by induction of p21 and attenuation of G2/M arrest.
Hassani S; Ghaffari SH; Zaker F; Mirzaee R; Mardani H; Bashash D; Zekri A; Yousefi M; Zaghal A; Alimoghaddam K; Ghavamzadeh A
Ann Hematol; 2013 Sep; 92(9):1207-20. PubMed ID: 23645216
[TBL] [Abstract][Full Text] [Related]
15.
Drozdkova DH; Gursky J; Minarik J; Überall I; Kolar Z; Trtkova KS
Anticancer Res; 2020 Sep; 40(9):4979-4987. PubMed ID: 32878786
[TBL] [Abstract][Full Text] [Related]
16. NEDD8 Inhibition Overcomes CKS1B-Induced Drug Resistance by Upregulation of p21 in Multiple Myeloma.
Huang J; Zhou Y; Thomas GS; Gu Z; Yang Y; Xu H; Tricot G; Zhan F
Clin Cancer Res; 2015 Dec; 21(24):5532-42. PubMed ID: 26156395
[TBL] [Abstract][Full Text] [Related]
17. The role of p21(waf1/cip1) and p27(Kip1) in HDACi-mediated tumor cell death and cell cycle arrest in the Eμ-myc model of B-cell lymphoma.
Newbold A; Salmon JM; Martin BP; Stanley K; Johnstone RW
Oncogene; 2014 Nov; 33(47):5415-23. PubMed ID: 24292681
[TBL] [Abstract][Full Text] [Related]
18. TPA-induced p21 expression augments G2/M arrest through a p53-independent mechanism in human breast cancer cells.
Han J; Kim S; Yang JH; Nam SJ; Lee JE
Oncol Rep; 2012 Feb; 27(2):517-22. PubMed ID: 22020547
[TBL] [Abstract][Full Text] [Related]
19. Curcumin induces G2/M arrest and triggers apoptosis via FoxO1 signaling in U87 human glioma cells.
Cheng C; Jiao JT; Qian Y; Guo XY; Huang J; Dai MC; Zhang L; Ding XP; Zong D; Shao JF
Mol Med Rep; 2016 May; 13(5):3763-70. PubMed ID: 27035875
[TBL] [Abstract][Full Text] [Related]
20. A novel phenylphthalimide derivative, pegylated TC11, improves pharmacokinetic properties and induces apoptosis of high-risk myeloma cells via G2/M cell-cycle arrest.
Aida S; Hozumi M; Ichikawa D; Iida K; Yonemura Y; Tabata N; Yamada T; Matsushita M; Sugai T; Yanagawa H; Hattori Y
Biochem Biophys Res Commun; 2017 Nov; 493(1):514-520. PubMed ID: 28867196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
